Cancer testis antigens

A new paradigm for cancer therapy

Anil Suri Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, IndiaCorrespondence[email protected]

Shikha Saini Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India

Abhilasha Sinha Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India

Sumit Agarwal Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India

Archana Verma Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India

Deepak Parashar Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India

Swarnendra Singh Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India

Namita Gupta Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India

Nirmala Jagadish Cancer Microarray; Genes and Proteins Laboratory; National Institute of Immunology; New Delhi, India